文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

急性肾损伤通向精准医学之路

The Road to Precision Medicine for Acute Kidney Injury.
PubMed 文献 · Crit Care Med · 2024-06-13
一句话结论急性肾损伤是涵盖多种潜在病理的综合征,其异质性阻碍了新疗法的开发;验证新型生物标志物、利用电子健康记录分类、肾小管分泌清除表型分型及正在进行的肾脏精准医学项目等,有望推进急性肾损伤精准医学。

该综述总结急性肾损伤精准医学的必要性证据,强调急性肾损伤是涵盖多种潜在病理的综合征,其异质性阻碍了新疗法的开发。改善精准性的努力包括验证新型生物标志物、利用电子健康记录进行疾病分类、肾小管分泌清除表型分型。正在进行的肾脏精准医学项目、识别急性肾损伤亚表型及优化临床试验和终点等,在推进急性肾损伤精准医学方面具有很大前景。

要点

  • 急性肾损伤是涵盖多种潜在病理的综合征,其异质性阻碍了新疗法的开发。
  • 过去十年急性肾损伤高死亡率未见可测量改善。
  • 验证新型生物标志物、利用电子健康记录进行疾病分类、肾小管分泌清除表型分型是改善精准性的努力方向。
  • 肾脏精准医学项目、识别急性肾损伤亚表型及优化临床试验和终点等正在进行的工作具有很大前景。

适用人群与场景

  • 重症监护病房中发生急性肾损伤的危重症患者

研究设计与关键结果

  • 综述定性评估并叙述性综合了与急性肾损伤精准医学相关的观察性研究、随机临床试验、综述、专业学会建议和指南。
  • 急性肾损伤是涵盖多种潜在病理的综合征,其异质性阻碍了新疗法的开发。
  • 过去十年急性肾损伤高死亡率未见可测量改善。
  • 改善急性肾损伤精准性的努力包括验证新型生物标志物、利用电子健康记录进行疾病分类、肾小管分泌清除表型分型。
  • 肾脏精准医学项目、识别急性肾损伤亚表型及优化临床试验和终点等正在进行的工作,在推进急性肾损伤精准医学方面具有很大前景。

证据类型、等级与局限

  • 综述:定性评估并叙述性综合观察性研究、随机临床试验、综述、专业学会建议和指南。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Acute kidney injury (AKI) is a common form of organ dysfunction in the ICU. AKI is associated with adverse short- and long-term outcomes, including high mortality rates, which have not measurably improved over the past decade. This review summarizes the available literature examining the evidence of the need for precision medicine in AKI in critical illness, highlights the current evidence for heterogeneity in the field of AKI, discusses the progress made in advancing precision in AKI, and provides a roadmap for studying precision-guided care in AKI.

DATA SOURCES: Medical literature regarding topics relevant to precision medicine in AKI, including AKI definitions, epidemiology, and outcomes, novel AKI biomarkers, studies of electronic health records (EHRs), clinical trial design, and observational studies of kidney biopsies in patients with AKI.

STUDY SELECTION: English language observational studies, randomized clinical trials, reviews, professional society recommendations, and guidelines on areas related to precision medicine in AKI.

DATA EXTRACTION: Relevant study results, statements, and guidelines were qualitatively assessed and narratively synthesized.

DATA SYNTHESIS: We synthesized relevant study results, professional society recommendations, and guidelines in this discussion.

CONCLUSIONS: AKI is a syndrome that encompasses a wide range of underlying pathologies, and this heterogeneity has hindered the development of novel therapeutics for AKI. Wide-ranging efforts to improve precision in AKI have included the validation of novel biomarkers of AKI, leveraging EHRs for disease classification, and phenotyping of tubular secretory clearance. Ongoing efforts such as the Kidney Precision Medicine Project, identifying subphenotypes in AKI, and optimizing clinical trials and endpoints all have great promise in advancing precision medicine in AKI.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Birkelo BC, Koyner JL, Ostermann M, et al. The Road to Precision Medicine for Acute Kidney Injury. Crit Care Med. 2024. PMID: 38869385. doi:10.1097/CCM.0000000000006328

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。